iShares NASDAQ Biotechnology I… (NASDAQ:IBB)

Biotechnology word cloud

Top Biotech Earnings Previews for the Week Ahead

Earnings season is now well under way for the second quarter. So far, things are looking good. The biotech sector has yet to see any significant earnings representation. That will ...
Read Full Story »
down market

Yellen Sees Social Media, Biotech, Junk Bonds and Leveraged Loans Overvalued

Fed Chair Janet Yellen offered a bit of a surprise in her semiannual Monetary Policy Report in front of Congress on Tuesday. It may seem like a bit like Alan ...
Read Full Story »
down market

Biotech: The Poster Child for Market Volatility in 2014

When 2014 began, no one promised the stock market would rise in a nice, smooth regal sort of way. Boy, were they right. Stocks have been subject to intense bursts ...
Read Full Story »
Traders

Eight Serious Market Indicators to Watch During This Correction

Any time a market peaks, investors and commentators talk about the expectations of a sell-off. The S&P 500 and Dow Jones Industrial Average peaked less than two weeks ago. Now ...
Read Full Story »
DNA

Large Cap Biotechs Trading With Only Big Pharma P/E Ratios

The iShares Nasdaq Biotechnology (NASDAQ: IBB) exchange traded fund (ETF) has pulled back almost 17% since the February 25 peak, in a sell-off likened to the August 2011 debacle. Trading ...
Read Full Story »
West side view of the United States Capitol building.

Top Biotechnology Stocks On Sale Again

For the second time in less than a month, the biotechnology sector got whacked when once again, chatter coming from the halls of Congress over drug pricing concerns hit the ...
Read Full Story »
biotech

Market Take: Biotech Suffers Under Government Shutdown Too!

The field of pharmaceuticals is very well established and often is considered to be a very defensive sector. As such, investors flock to the drug sector in times of uncertainty. ...
Read Full Story »
Stock Split Image

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Biotech stocks come and go as far as the flavor of the day for investors. While many of these companies are risky, and while many are too risky for many ...
Read Full Story »
biotech

Daily ETF Folly: Why There Is No True Biotech Representation in ETFs

24/7 Wall St. is taking a daily aim at the world exchange-traded funds (ETFs). Many are great, and many are actively traded and truly represent what investors are trying to ...
Read Full Story »
biotech

ETF Folly: Biotech ETFs, Nothing but Confusion

24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the sector performed ...
Read Full Story »
biotech

Analyst: Biogen Idec Gains Are Done

Biogen Idec Inc. (NASDAQ: BIIB) has had a great 2012. Actually, it has had a hell of a year with a gain of almost 40% year to date. When you compare this ...
Read Full Story »

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), ...
Read Full Story »

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), ...
Read Full Story »

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September 28 settlement dates. There were notable swings in shares sold ...
Read Full Story »

Short Interest in Biotech on the Rise (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short interest changes from September 14 settlement date versus the August ...
Read Full Story »